International differences in chronic kidney disease prevalence: A key public health and epidemiologic research issue

Nephrology Dialysis Transplantation

Volumn 32, Issue , 2017, Pages ii129-ii135

  Stel, Vianda S ^a   Brück, Katharina ^a   Fraser, Simon ^b   Zoccali, Carmine ^c   Massy, Ziad A ^d,e   Jager, Kitty J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c CNR   (Italy)

^d HÔPITAL AMBROISE PARÉ   (France)

^e CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

Author keywords

Cardiovascular mortality; Chronic kidney disease; Health policy; Prevalence; Risk factor

Indexed keywords

BODY MASS; CARDIOVASCULAR MORTALITY; CHRONIC KIDNEY FAILURE; DIABETES MELLITUS; DISEASE COURSE; ELEVATED BLOOD PRESSURE; EPIDEMIOLOGICAL DATA; HEALTH CARE POLICY; HEALTH PROMOTION; HUMAN; LIFESTYLE MODIFICATION; OBESITY; PHYSICAL ACTIVITY; PHYSICAL INACTIVITY; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; RISK FACTOR; RISK REDUCTION; SALT INTAKE; SMOKING; EUROPE; LIFESTYLE; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC;

DISEASE PROGRESSION; EUROPE; HUMANS; LIFE STYLE; PREVALENCE; PUBLIC HEALTH; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 85019117181     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfw420     Document Type: Review

References (33)

1. Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet 2013; 382: 339-352
2. Coresh J, Turin TC, Matsushita K, et al. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA 2014; 311: 2518-2531
3. Keith DS, Nichols GA, Gullion CM, et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004; 164: 659-663
4. Kramer A, Pippias M, Stel VS, et al. Renal replacement therapy in Europe: a summary of the 2013 ERA-EDTA Registry Annual Report with a focus on diabetes mellitus. Clin Kidney J 2016; 9: 457-469
5. Ware JE Jr, Gandek B, Guyer R, et al. Standardizing disease-specific quality of life measures across multiple chronic conditions: development and initial evaluation of the QOL Disease Impact Scale (QDISVR ). Health Qual Life Outcomes 2016; 14: 84
6. Evans RW, Manninen DL, Garrison LP Jr, et al. The quality of life of patients with end-stage renal disease. N Engl JMed 1985; 312: 553-559
7. Karopadi AN, Mason G, Rettore E, et al. Cost of peritoneal dialysis and haemodialysis across the world.Nephrol Dial Transplant 2013; 28: 2553-2569
8. Haller M, Gutjahr G, Kramar R, et al. Cost-effectiveness analysis of renal replacement therapy in Austria. Nephrol Dial Transplant 2011; 26: 2988-2995
9. Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease: global dimension and perspectives. Lancet 2013; 382: 260-272
10. Dunkler D, Kohl M, Teo KK, et al. Population-Attributable fractions of modifiable lifestyle factors for CKD and mortality in individuals with type 2 diabetes: a cohort study. Am J Kidney Dis 2016; 68: 29-40
11. Brück K, Stel VS, Fraser S, et al. Translational research in nephrology: chronic kidney disease prevention and public health. Clin Kidney J 2015; 8: 647-655
12. Brück K, Stel VS, Gambaro G, et al. CKD prevalence varies across the European general population. J Am Soc Nephrol 2016; 27: 2135-2147
13. Fraser SD, Aitken G, Taal MW, et al. Exploration of chronic kidney disease prevalence estimates using new measures of kidney function in the health survey for England. PLOS One 2015; 10: e0118676
14. Myers GL, Miller WG, Coresh J, et al. Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem 2006; 52: 5-18
15. Warburton DE, Nicol CW, Bredin SS. Health benefits of physical activity: the evidence. CMAJ 2006; 174: 801-809
16. Hallan SI, Orth SR. Smoking is a risk factor in the progression to kidney failure. Kidney Int 2011; 80: 516-523
17. Thijssen S, Kitzler TM, Levin NW. Salt: its role in chronic kidney disease. J Ren Nutr 2008; 18: 18-26
18. WHO. Noncommunicable Diseases Country Profiles 2014. Geneva: World Health Organization, 2014
19. Prevalence of chronic kidney disease and associated risk factors-United States, 1999-2004.MMWRMorb Mortal Wkly Rep 2007; 56: 161-165
20. Kainz A, Hronsky M, Stel VS, et al. Prediction of prevalence of chronic kidney disease in diabetic patients in countries of the European Union up to 2025. Nephrol Dial Transplant 2015; 30 (Suppl 4): iv113-iv118
21. Bachmann LM, Nilsson G, Bruns DE, et al. State of the art for measurement of urine albumin: comparison of routine measurement procedures to isotope dilution tandem mass spectrometry. Clin Chem 2014; 60: 471-480
22. Cuhadar S, Koseoglu M, Atay A, et al. The effect of storage time and freezethaw cycles on the stability of serum samples. Biochem Med 2013; 23: 70-77
23. Delanaye P, Cavalier E, Cristol JP, et al. Calibration and precision of serum creatinine and plasma cystatin C measurement: impact on the estimation of glomerular filtration rate. J Nephrol 2014; 27: 467-475
24. Scholes S, Mindell J. Chapter 2: Physical activity in adults. In Health Survey England. 2012, 1-49.
25. Statistiek CBvd. Gezondheidsenquete. The Hague: CBS, 2012
26. Bala MM, Strzeszynski L, Topor-Madry R, et al. Mass media interventions for smoking cessation in adults. Cochrane Database Syst Rev 2013; 6
27. Webster J, Trieu K, Dunford E, et al. Target salt 2025: a global overview of national programs to encourage the food industry to reduce salt in foods. Nutrients 2014; 6: 3274-3287
28. Gilbert A, Cornuz J. Which are the most effective and cost-effective interventions for tobacco control? Copenhagen, WHO Regional Office for Europe (Health Evidence Network report; http://www.euro.who.int/document/e82993.pdf) (2May 2016, date last accessed).
29. Survey on Member States' implementation of the EU Salt Reduction Framework. http://ec.europa.eu/health/nutrition-physical-Activity/docs/salt-report1-en.pdf (2May 2016, date last accessed).
30. Mc Mahon EJ, Campbell KL, Bauer JD, et al. Altered dietary salt intake for people with chronic kidney disease. Cochrane Database Syst Rev 2015; 18
31. Halimi JM, Giraudeau B, Vol S, et al. Effects of current smoking and smoking discontinuation on renal function and proteinuria in the general population. Kidney Int 2000; 58: 1285-1292
32. Benghanem Gharbi M, Elseviers M, Zamd M, et al. Chronic kidney disease, hypertension, diabetes, and obesity in the adult population of Morocco: how to avoid 'over'-And 'under'-diagnosis of CKD. Kidney Int 2016; 89: 1363-1371
33. Girndt M, Trocchi P, Scheidt-Nave C, et al. The prevalence of renal failure. Results from the German Health Interview and Examination Survey for adults, 2008-2011 (DEGS1). Dtsch Arztebl Int 2016; 113: 85-91